Dr. David Griffith, MD

Pulmonary Disease Denver, CO Male
NPI: 1245229301
Total Payments
$287,061
2024 Payments
$31,987
Companies
17
Transactions
270
Medicare Patients
667
Medicare Billing
$102,540

Payment Breakdown by Category

Consulting$149,123 (51.9%)
Travel$76,168 (26.5%)
Other$54,813 (19.1%)
Food & Beverage$6,819 (2.4%)
Education$137.99 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $149,123 44 51.9%
Travel and Lodging $76,168 85 26.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $52,425 21 18.3%
Food and Beverage $6,819 116 2.4%
Honoraria $2,388 2 0.8%
Education $137.99 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Insmed, Inc. $237,010 208 $0 (2024)
Grifols Shared Services North America, Inc. $18,736 13 $0 (2017)
VERTEX PHARMACEUTICALS INCORPORATED $14,496 11 $0 (2019)
Merck Sharp & Dohme Corporation $6,896 8 $0 (2019)
Grifols USA, LLC $3,715 6 $0 (2017)
Horizon Pharma plc $3,003 4 $0 (2017)
Paratek Pharmaceuticals, Inc. $2,654 2 $0 (2021)
Mannkind Corporation $273.29 2 $0 (2022)
GlaxoSmithKline, LLC. $86.76 5 $0 (2018)
Genentech USA, Inc. $73.61 3 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $31,987 12 Insmed, Inc. ($31,987)
2023 $37,852 26 Insmed, Inc. ($37,832)
2022 $44,711 43 Insmed, Inc. ($44,411)
2021 $17,398 21 Insmed, Inc. ($14,743)
2020 $61,775 59 Insmed, Inc. ($61,775)
2019 $56,834 63 Insmed, Inc. ($46,263)
2018 $10,926 16 Vertex Pharmaceuticals Incorporated ($10,821)
2017 $25,579 30 Grifols Shared Services North America, Inc. ($18,736)

All Payment Transactions

270 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/19/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $3.22 General
Category: Respiratory
12/17/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $9.18 General
Category: Respiratory
12/10/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $146.59 General
Category: Respiratory
09/27/2024 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $3,000.00 General
Category: Respiratory
09/10/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $124.13 General
Category: Respiratory
08/03/2024 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $12,562.50 General
Category: Respiratory
08/03/2024 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $11,532.84 General
Category: Respiratory
08/03/2024 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $1,626.54 General
Category: Respiratory
08/03/2024 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $595.24 General
Category: Respiratory
08/02/2024 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $2,250.00 General
Category: Respiratory
05/18/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $121.50 General
Category: Respiratory
01/17/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $14.76 General
Category: Respiratory
11/18/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: Respiratory
10/13/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: Respiratory
09/18/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $13.96 General
Category: Respiratory
09/13/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $3.37 General
Category: Respiratory
09/09/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $100.58 General
Category: Respiratory
08/23/2023 Insmed, Inc. — Consulting Fee Cash or cash equivalent $3,900.00 General
08/08/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $2.24 General
Category: Respiratory
07/12/2023 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $2.12 General
Category: Respiratory
07/02/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $1,950.00 General
Category: Respiratory
07/01/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $12,379.47 General
Category: Respiratory
07/01/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $7,800.00 General
Category: Respiratory
07/01/2023 Insmed, Inc. Arikayce (Drug) Consulting Fee Cash or cash equivalent $2,275.00 General
Category: Respiratory
07/01/2023 Insmed, Inc. Arikayce (Drug) Travel and Lodging In-kind items and services $583.04 General
Category: Respiratory
123…11»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 255 381 $69,682 $35,651
2022 3 251 387 $78,635 $43,218
2021 3 126 176 $33,800 $18,905
2020 2 35 42 $10,140 $4,765
Total Patients
667
Total Services
986
Medicare Billing
$102,540
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 85 139 $28,633 $15,300 53.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 117 188 $28,675 $14,607 50.9%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 18 18 $5,265 $2,436 46.3%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 19 19 $4,549 $2,046 45.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 17 $2,560 $1,263 49.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 143 247 $50,635 $29,139 57.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 50 50 $14,500 $7,166 49.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 58 90 $13,500 $6,913 51.2%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 55 76 $15,580 $9,145 58.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 48 77 $11,550 $6,275 54.3%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 23 23 $6,670 $3,485 52.3%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 18 18 $5,220 $2,535 48.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 17 24 $4,920 $2,230 45.3%

About Dr. David Griffith, MD

Dr. David Griffith, MD is a Pulmonary Disease healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245229301.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Griffith, MD has received a total of $287,061 in payments from pharmaceutical and medical device companies, with $31,987 received in 2024. These payments were reported across 270 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($149,123).

As a Medicare-enrolled provider, Griffith has provided services to 667 Medicare beneficiaries, totaling 986 services with total Medicare billing of $102,540. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Other Specialties Infectious Disease
  • Location Denver, CO
  • Active Since 10/20/2005
  • Last Updated 05/13/2025
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1245229301

Products in Payments

  • Arikayce (Drug) $182,458
  • QUINSAIR (Drug) $3,003
  • NUZYRA (Drug) $2,654
  • AFREZZA (Drug) $273.29
  • BREO (Drug) $47.78
  • Esbriet (Biological) $38.00
  • UTIBRON (Drug) $22.12
  • SMARTVEST (Device) $20.43
  • ANORO (Drug) $19.88
  • Perforomist (Drug) $15.59
  • Hillrom - Vest System Model 105 Home Care (Device) $14.84
  • Trilogy 100 (Device) $13.46
  • OPSUMIT MACITENTAN (Drug) $12.71
  • AVYCAZ (Drug) $12.54
  • Xolair (Biological) $11.39
  • BROVANA (Drug) $5.57

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in Denver

Dr. Ronald Balkissoon, Md, MD

Pulmonary Disease — Payments: $1.5M

Pulmonary Disease $1.5M

Kevin Brown, Md, MD

Pulmonary Disease — Payments: $333,953

Pulmonary Disease $333,953

Barry Make, Md, MD

Pulmonary Disease — Payments: $244,103

Pulmonary Disease $244,103

Dr. David Beuther, Md, MD

Pulmonary Disease — Payments: $155,207

Pulmonary Disease $155,207

Evans Fernandezperez, M.d, M.D

Pulmonary Disease — Payments: $149,782

Pulmonary Disease $149,782

Dr. Robert Sandhaus, M.d., Ph.d, M.D., PH.D

Pulmonary Disease — Payments: $106,680

Pulmonary Disease $106,680